MedAxiom, the premier source for cardiovascular organizational performance solutions, has released its ninth annual Cardiovascular Provider Compensation and Production Survey Report revealing the true impact of the coronavirus pandemic on cardiovascular programs in 2020. While cardiology production was significantly down, cardiology compensation fared well in 2020. In fact, private group cardiologist compensation rose. Separately, a new patient panel measure shows a downward trend for median physician FTE per 1,000 active patients suggesting that the cardiology community is moving more care to APPs as part of its clinical strategy.
Novocardia, a value-based cardiovascular disease care delivery platform, today announced a partnership with First Coast Heart & Vascular Center, P.C., the largest independent cardiovascular disease physician group in Northeast Florida. Established in 2013, First Coast Heart & Vascular Center has grown rapidly to serve thousands of patients across Florida’s largest geographic market. First Coast Heart & Vascular Center employs sixteen cardiologists and eight advanced practice providers serving patients at nine practice locations across Duval, St. Johns, Flagler, Putnam and Clay counties.
Novocardia, a value-based cardiovascular care delivery platform, announced Monday a $53.7 million Series A financing led by Deerfield Management Company. Novocardia is partnering with cardiologists to help them to grow their practices and navigate an increasingly complex healthcare landscape through participation in fee-for-value (FFV) reimbursement models. The company’s mission is to deliver better care at lower cost, through more proactive and prevention-focused care, leveraging technology, and creating aligned partnerships with health plans and referral partners.
As CMS continues to remove cardiology surgeries from its inpatient-only list, ASC leaders expect these procedures to be critical to ASC growth. Four ASC leaders joined Becker’s Spine, Orthopedic & Pain Management-Driven ASC + The Future of Spine Conference hosted June 8-17. Here, they discuss the biggest opportunities for ASC growth post-pandemic.
The U.S. saw remarkable increases in the death rates for heart disease, diabetes and some other common killers in 2020, and experts believe a big reason may be that many people with dangerous symptoms made the lethal mistake of staying away from the hospital for fear of catching the coronavirus. The death rates — posted online this week by federal health authorities — add to the growing body of evidence that the number of lives lost directly or indirectly to the coronavirus in the U.S. is far greater than the officially reported COVID-19 death toll of nearly 600,000 in 2020-21.
AliveCor, the global leader in FDA-cleared personal electrocardiogram (ECG) technology and services, announced Wednesday that it has acquired the independent diagnostic testing facility (IDTF) CardioLabs, a leading monitoring and cardiac diagnostic service provider. The acquisition is a cornerstone of AliveCor’s mission to extend its comprehensive cardiological services to patients who are prescribed monitoring devices by their healthcare providers. With the acquisition, AliveCor now manages CardioLabs’ U.S.-based healthcare provider customers and plans to expand the service to new customers in the coming months.
Generational Capital Markets is pleased to announce the sale of Navix Holdings Corp. and its subsidiary, Navix Diagnostix, Inc. (a portfolio company of Prospect Partners) to a Private Investment Firm. The acquisition closed April 30, 2021. Prospect Partners is a leading lower-middle-market private equity firm based in Chicago. Located in Taunton, Massachusetts, Navix Diagnostix, Inc. (Navix) is the market leader in providing outsourced cardiovascular services, specializing in the management of noninvasive vascular labs.
Single-specialty cardiology ASCs are rapidly rising, and there are plenty of indications that the steep climbs witnessed in recent years will continue apace in the years to come. In this article, GHA highlights several points of consideration with respect to cardiology ASCs.
Anderson Heart, PC (Anderson Heart or AH), an independent cardiology and vascular surgery practice headquartered in Anderson, South Carolina, has partnered with Azura Vascular Care (Azura) and National Cardiovascular Partners, LP (NCP), together wholly owned by Fresenius Medical Care North America, to form a newly created joint venture (Joint Venture) that completes an equity recapitalization and focuses on a growth strategy of physician recruitment and providing high-quality medical care to patients throughout South Carolina.
Center for Vein Restoration (CVR), the national leader in treating varicose and spider veins, has announced a new partnership with Dr. Michael Harding of Vein Center of New Mexico. This location in Albuquerque, New Mexico, adds to our growing footprint of over 100 centers nationwide. Dr. Harding is board-certified in cardiovascular disease, internal medicine, and vascular medicine. He is a Diplomate of the American Board of Venous and Lymphatic Medicine; registered Phlebology Sonographer; and registered physician in vascular interpretation.
What We Do
Who We Are
How We Work
Who We Help
Get In Touch
Connect With Us
Subscribe to Our Daily Note
We publish a Daily Note that aggregates M&A activity, notable developments, regulatory changes, and conferences we deem to be of interest to our partners. It is a quick afternoon read and an easy way to keep your finger on the pulse of the healthcare space. Please fill in your name and email address below if you wish to subscribe.